As per the report titled ‘Global Nasal High Flow Market - Analysis By Type, Addressable Market: Opportunities and Forecast (2019-2024)’, available with Market Study Report, global nasal high flow market was worth USD 2,563.25 million in the year 2018, and is expected to record substantial growth over 2019-2024.
 

The global nasal high flow market is catalyzed by factors such as growing geriatric population, increasing prevalence of respiratory diseases, escalating air pollution levels, and surging demand for homecare products.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2361878/
 

For those uninitiated, nasal high flow therapy supplies oxygen with a higher flow rate to assist critically ill patients in breathing. Further advancements in nasal high flow will help the patients recover sooner and provide solutions that can avoid acute conditions. There is a lot of scope for developing new devices such as nebulization.
 

Speaking of the end-user scope, the market has been bifurcated into hospital, homecare, and others segments. In terms of product type, the market has been fragmented into consumables and devices.
 

Based on regional landscape, U.S. holds majority of the market share owing to increasing investments made in R&D and presence of technologically advanced devices. However, Canada, China, and the ROW are slated to record notable growth rate in the subsequent years owing to increasing investments made in the upstream sector.
 

Flexicare Medical, Vapotherm, Fisher and Paykel Healthcare, ResMed, and Vyaire Medical among others are the well-established companies operating in global nasal high flow market.